| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,172 | 0,195 | 12.05. | |
| 0,172 | 0,197 | 12.05. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.04. | KLEA HOLDING: Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026 | 369 | Actusnews Wire | Annual revenue growth of 28%, to €22.2 million.
57% increase in EBITDA and normalized EBITDA, representing a margin of 31%.
Operating income doubled to €3.4 million.
Net income attributable... ► Artikel lesen | |
| 01.04. | KLEA HOLDING: Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals | 379 | Actusnews Wire | Paris, 1 April 2026
KLEA HOLDING (FR0013481835 - ALKLH), a group specialising in the acquisition, development and digitalisation of businesses across various sectors, announces the creation of... ► Artikel lesen | |
| 19.01. | KLEA HOLDING: Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates | 692 | Actusnews Wire | Strong performance (+25% at constant currency) in the Medical Fitness segment.
Revenue from the Medical Fitness segment & other services increased by a factor of 2.5.
Confirmation of the target... ► Artikel lesen | |
| 27.10.25 | KLEA HOLDING: Klea Holding strengthens its presence in Dubai with its first strategic real estate investment in the flagship Lumena Alta project | 549 | Actusnews Wire | Paris, 27 October 2025
KLEA HOLDING (FR0013481835 - ALKLH), a group specialising in the acquisition, development and digitalisation of companies in various sectors, announces its first real estate... ► Artikel lesen | |
| 17.10.25 | KLEA HOLDING: Klea Holding confirms its hypergrowth in the Q3 2025 and its annual targets | 721 | Actusnews Wire | Number of tests performed increased by +35% in Q3 and by +48% at the end of the 9M of the financial year.
New revenue record in September 2025 in the Health & Wellness segment.
Work resumes... ► Artikel lesen | |
| 25.09.25 | KLEA HOLDING: Klea Holding repurchases the remaining PARK warrants in order to definitively cancel the last dilutive instruments | 501 | Actusnews Wire | Paris, 25 September 2025
KLEA HOLDING (FR0013481835 - ALKLH), a group focused on the acquisition, development and digital transformation of companies in various sectors, announces that it has repurchased... ► Artikel lesen | |
| 22.09.25 | KLEA HOLDING: Klea Holding significantly improves its half-year results and confirms its targets thanks to very positive business trends | 419 | Actusnews Wire | +46% growth in half-yearly revenue, driven by an increase in the number of tests.
+118% growth in normalised EBITDA (€3.9m), representing a normalised margin of 33.8%.
€2.6m in consolidated... ► Artikel lesen | |
| 01.09.25 | KLEA HOLDING: Klea Holding repurchases and cancels PARK warrants to limit shareholder dilution | 835 | Actusnews Wire | KLEA HOLDING (FR0013481835 - ALKLH), a group focused on the acquisition, development and digital transformation of businesses across multiple sectors, announces the repurchase and cancellation... ► Artikel lesen | |
| KLEA HOLDING Aktie jetzt für 0€ handeln | |||||
| 21.07.25 | KLEA HOLDING: Klea Holding accelerates its growth in the first half of 2025 | 905 | Actusnews Wire | Number of tests performed up by +55% compared with +24% in 2024;
Sales up +48% at constant exchange rates;
Confirmation of development and performance plan.
Paris, 21 July 2025
KLEA HOLDING... ► Artikel lesen | |
| 12.06.25 | KLEA HOLDING: Klea Holding adopts a new governance structure and presents its strategy and objectives | 745 | Actusnews Wire | KLEA HOLDING (FR0013481835 - ALKLH), a group focused on the acquisition, development and digitalization of companies across multiple sectors, announces the successful holding of its Annual General... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,750 | 0,00 % | Geratherm Medical wechselt vom Börsensegment Scale in den Open Market | Die Geratherm Medical AG beendet zum 27. April 2026 die Einbeziehung ihrer Aktien in das Börsensegment Scale der Frankfurter Wertpapierbörse und wechselt ins Basic Board am Open Market. Die Börsennotierung... ► Artikel lesen | |
| MEDICLIN | 3,580 | 0,00 % | EQS-News: MEDICLIN AG: MEDICLIN steigert Betriebsergebnis im ersten Quartal | EQS-News: MEDICLIN AG
/ Schlagwort(e): Quartals-/Zwischenmitteilung
MEDICLIN steigert Betriebsergebnis im ersten Quartal
04.05.2026 / 13:08 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,190 | -0,93 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Reports 2025 Annual Results: Corporate Health Management Business Posts Strong Growth; AI Healthcare Deployment Accelerates | HONG KONG, March 24, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its annual results for... ► Artikel lesen | |
| EMEIS | 14,460 | -1,23 % | emeis: Revenue and Business Activity as of the End of March 2026 | Recovery momentum continues in the first quarter
Occupancy rates rose across all regions to 89.1% (up 2.1 points on average)
Organic revenue growth of +6.3% in the first quarter
Regulatory News:... ► Artikel lesen | |
| CONVATEC | 2,380 | +0,85 % | Die fortschrittlichen Innovationen von Convatec im Bereich der Wundversorgung setzen auf der European Wound Management Association (EWMA) 2026 neue Maßstäbe in der Branche | Convatec wird neue klinische und praxisbezogene Erkenntnisse zu Schaumstofftechnologien der nächsten Generation, Stickstoffmonoxid freisetzenden Verbänden und Wundhygiene vorstellen Von... ► Artikel lesen | |
| HAEMONETICS | 46,000 | +3,60 % | Haemonetics projects FY 2027 revenue growth of 4% to 7% as Persona PLUS rollout and IVT rebound efforts continue | ||
| THERMA BRIGHT | 0,023 | +18,42 % | Therma Bright Inc.: Therma Bright Announces Follow-On Order from Horizon Health as Venowave Gains Traction in U.S. Vascular Markets | Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced... ► Artikel lesen | |
| LEMAITRE VASCULAR | 84,00 | -2,89 % | 3 Reasons Growth Investors Will Love LeMaitre (LMAT) | ||
| PULSE BIOSCIENCES | 17,100 | +4,91 % | Pulse Biosciences: Aktie springt nach Insiderkäufen in Millionenhöhe | ||
| SEDANA MEDICAL | 0,823 | -3,29 % | Sedana Medical AB: Sedana Medical AB's Interim report January-March 2026 | Positive Group EBITDA despite market headwinds
First quarter 2026Net sales for the quarter totaled MSEK 53.4 (57.5), equivalent to a decrease of 7% compared to the corresponding quarter in 2025. At... ► Artikel lesen | |
| TERVEYSTALO | 7,660 | -1,16 % | Terveystalo Oyj: Terveystalo Group Interim Report January-March 2026: Despite the difficult demand environment, profitability remained at a good level | Terveystalo Plc, Interim Report 24 April 2026 at 09:00 EEST
This release is a summary of Terveystalo's Interim Report January-March 2026. The full release is attached to this stock exchange release... ► Artikel lesen | |
| GAROFALO HEALTH CARE | 5,160 | +1,98 % | Garofalo Health Care S.P.A Reveals Climb In Full Year Profit | ||
| INTEGRATED DIAGNOSTICS | 0,462 | -1,70 % | Integrated Diag Hdgs - Replacement - Holding(s) in Company | ||
| FRESENIUS | 39,520 | -0,90 % | EQS-News: Fresenius SE & Co. KGaA: Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt (News... ► Artikel lesen |